Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine
AssigneeZeon Corporation
InventorsTakanori Sato, Yoshinari Tsuzaki, Motoyuki Esaki, Kristi M. Dorsey
Life of this patent
Estimating the term…
Abstract
The present invention provides an avian recombinant herpesvirus modified by the presence of the cDNA encoding, the VP2 of the Delaware Variant E strain of IBDV, a subtype of IBDV serotype 1 strains. The present invention further provides an avian recombinant herpesvirus comprised of the VP2 gene of which the backbone virus is a Marek's disease vaccine strain, such as herpesvirus of turkeys. A poultry vaccine including the avian herpes recombinant virus described in the present invention can induce in chickens protective immunity against a variety of different subtypes of IBDV.
Claims8
1:
- An avian recombinant herpesvirus modified by the insertion of cDNA encoding VP2 of the Delaware Variant E strain of IBDV into the region of the herpesvirus genome which is non-essential for the virus growth.
2:
- An avian recombinant herpesvirus as in claim 1 wherein the sequence of cDNA encoding VP2 is that shown in SEQ ID NO. 1.
3-5 (Canceled).
6:
- An avian recombinant herpesvirus as in claim 1, wherein the said herpesvirus is herpesvirus of turkeys.
7:
- An avian recombinant herpesvirus as in claim 1 wherein said herpesvirus is the SB1 strain of the serotype 2 Marek's disease virus.
8:
- An avian recombinant herpesvirus as in claim 1 wherein the herpesvirus is the Rispens strain of the serotype 1 Marek's disease virus.
9:
- An Infectious Bursal Disease vaccine comprising the avian recombinant herpesvirus as in claim 1.
10 (Canceled).